ALBENZA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Albenza, and what generic alternatives are available?
Albenza is a drug marketed by Impax Labs Inc and is included in one NDA.
The generic ingredient in ALBENZA is albendazole. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the albendazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Albenza
A generic version of ALBENZA was approved as albendazole by STRIDES PHARMA on December 7th, 2018.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALBENZA?
- What are the global sales for ALBENZA?
- What is Average Wholesale Price for ALBENZA?
Summary for ALBENZA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 157 |
| Clinical Trials: | 3 |
| Patent Applications: | 3,500 |
| Drug Prices: | Drug price information for ALBENZA |
| What excipients (inactive ingredients) are in ALBENZA? | ALBENZA excipients list |
| DailyMed Link: | ALBENZA at DailyMed |
Recent Clinical Trials for ALBENZA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Lihir Medical Centre | Phase 3 |
| Institut de Recherche pour le Developpement | Phase 3 |
| Christian Medical College, Vellore, India | Phase 3 |
Pharmacology for ALBENZA
| Drug Class | Anthelmintic |
| Mechanism of Action | Cytochrome P450 1A Inducers |
US Patents and Regulatory Information for ALBENZA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Impax Labs Inc | ALBENZA | albendazole | TABLET;ORAL | 020666-001 | Jun 11, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
